Comparison of Total Corneal Astigmatism between IOLMaster and Pentacam.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2022
Historique:
received: 24 01 2022
revised: 27 05 2022
accepted: 17 06 2022
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 20 7 2022
Statut: epublish

Résumé

To compare the total corneal astigmatism (TCA) measured by IOLMaster 700 and Pentacam and to investigate the consistency of corneal keratometry (CK) measured by IOLMaster and Pentacam. Cataract patients were retrospectively enrolled in March and April, 2021. Retrospective analysis was performed on those patients with binocular and monocular CK measured by IOLMaster and Pentacam. A total of 102 patients (204 eyes) were included, 64 of whom were female (62.75%). The flat (K1) and steep (K2) CK of anterior corneal surface (ACS) and flat (TK1) and steep (TK2) of total cornea measured with IOLMaster 700 were 44.16 ± 1.60 D, 45.09 ± 1.68 D, 44.12 ± 1.62 D, and 45.14 ± 1.69 D, respectively. Those measured with Pentacam were 44.31 ± 1.57 D, 45.22 ± 1.65 D, 44.15 ± 1.67 D, and 45.19 ± 1.82 D, respectively. The astigmatism of ACS and TCA were -0.94 ± 0.63 D and -1.02 ± 0.69 D ( Total corneal astigmatism measured by IOLMaster was consistent with that measured by Pentacam. The difference between the astigmatism of anterior corneal surface and total cornea was detected in the measurement of IOLMaster and Pentacam, respectively.

Identifiants

pubmed: 35845936
doi: 10.1155/2022/9236006
pmc: PMC9286877
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9236006

Informations de copyright

Copyright © 2022 Xiaochun Li et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

J Cataract Refract Surg. 2012 Dec;38(12):2080-7
pubmed: 23069271
Sci Rep. 2020 Feb 21;10(1):3134
pubmed: 32081868
Am J Ophthalmol. 2014 Nov;158(5):863-74
pubmed: 25127696
Photodiagnosis Photodyn Ther. 2020 Dec;32:101976
pubmed: 32841750
Med Hypothesis Discov Innov Ophthalmol. 2019 Fall;8(3):177-203
pubmed: 31598520
Ther Adv Ophthalmol. 2022 Mar 31;14:25158414211063283
pubmed: 35387236
PLoS One. 2022 May 24;17(5):e0268856
pubmed: 35609043
Vet Ophthalmol. 2015 Jan;18(1):13-9
pubmed: 24548653
Graefes Arch Clin Exp Ophthalmol. 2021 May;259(5):1199-1207
pubmed: 33449216
J Cataract Refract Surg. 2012 Oct;38(10):1764-70
pubmed: 22999600
J Cataract Refract Surg. 2010 Aug;36(8):1323-9
pubmed: 20656155
BMC Ophthalmol. 2021 Jan 27;21(1):62
pubmed: 33504333
J Refract Surg. 1999 Sep-Oct;15(5):538-49
pubmed: 10504078
Indian J Ophthalmol. 2020 Dec;68(12):2732-2743
pubmed: 33229649
Am J Ophthalmol. 2009 Oct;148(4):528-535.e1
pubmed: 19541287
Curr Eye Res. 2012 Dec;37(12):1091-8
pubmed: 22916682
Indian J Ophthalmol. 2022 Apr;70(4):1150-1157
pubmed: 35326004
J Cataract Refract Surg. 2013 Oct;39(10):1550-60
pubmed: 23876813
Am J Ophthalmol. 2009 May;147(5):788-95, 795.e1-2
pubmed: 19232562
Optom Vis Sci. 2013 Apr;90(4):385-91
pubmed: 23435222
Clin Exp Ophthalmol. 2022 May 7;:
pubmed: 35524701
J Cataract Refract Surg. 2012 Sep;38(9):1608-15
pubmed: 22795977
J Refract Surg. 2013 Feb;29(2):114-20
pubmed: 23380412
J Ophthalmic Vis Res. 2018 Apr-Jun;13(2):93-100
pubmed: 29719635
J Clin Med. 2022 Jan 28;11(3):
pubmed: 35160160
Clin Ophthalmol. 2020 Nov 18;14:3991-4003
pubmed: 33239862
PLoS One. 2012;7(9):e45607
pubmed: 23049823
Int Ophthalmol. 2021 Jun;41(6):2205-2212
pubmed: 33733281
J Ophthalmol. 2020 Apr 01;2020:3012748
pubmed: 32318277
J Cataract Refract Surg. 2018 Oct;44(10):1192-1197
pubmed: 30243393
J Cataract Refract Surg. 2013 Oct;39(10):1561-9
pubmed: 23860010
J Cataract Refract Surg. 2011 Feb;37(2):295-301
pubmed: 21241912
Clin Ophthalmol. 2020 Oct 14;14:3325-3330
pubmed: 33116383
J Cataract Refract Surg. 2022 Mar 24;:
pubmed: 35333822
Ann Transl Med. 2020 Nov;8(22):1553
pubmed: 33313298
J Cataract Refract Surg. 2015 Feb;41(2):364-71
pubmed: 25661130
Am J Ophthalmol. 2013 Sep;156(3):460-467.e2
pubmed: 23810477

Auteurs

Xiaochun Li (X)

Department of Ophthalmology, Peking University People's Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.
Department of Ophthalmology, Peking University International Hospital, 1 Shengmingyuan Road, Life Science Park, Changping District, Beijing 102206, China.

Xiaoguang Cao (X)

Department of Ophthalmology, Peking University People's Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.

Yongzhen Bao (Y)

Department of Ophthalmology, Peking University People's Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH